State lawmakers approved a law requiring monthly heavy‑metal testing and public posting of results for baby food and, for the first time, infant formula.

A state‑funded, $32 million, 60‑bed recovery center opened on Wards Island to provide medication‑assisted treatment and stabilization for men in early recovery.

NYC Health + Hospitals is opening a second Bridge to Home site in Crown Heights, adding 50 private rooms and 24/7 clinical care to help residents secure permanent housing.

NYU's Dr. Jinsy Andrews breaks down gene-targeted ALS advances and offers practical brain-health tips for patients and caregivers.

NYC launched a $500K multilingual campaign through June to connect New Yorkers with free enrollment counselors as federal changes threaten coverage. The city is offering phone and online help.

The Health Department alerted One Haven Plaza residents after two tenants were diagnosed with Legionnaires in the last 11 months. Officials urge anyone with fever or cough to seek care.

The FDA cleared Enhertu for neoadjuvant and adjuvant treatment of HER2‑positive early breast cancer after DESTINY trials showed higher pCR and lower recurrence risk.

NewYork‑Presbyterian reported a $240M net loss even as operating income improved, underscoring how non‑operating swings can overwhelm hospital finances.

New reviews and large U.S. studies link extreme heat to higher maternal complications; experts urge more prenatal guidance, cooling access and workplace protections in NYC.

Northwell and the 32BJ Health Fund signed a direct-care pact covering 170,000 members that aims to cut hospital spending by roughly 20 percent and slash copays.

Attendees at a Metropolitan Opera performance in April were warned they may have been exposed to measles. Health officials advise anyone unsure of immunity to consult a clinician.

Mayor Zohran Mamdani held a May 7 press conference to announce plans for opioid settlement funds as the city continues directing settlement money to overdose prevention and treatment.

Memorial Sloan Kettering posted a $47.9M operating loss for 2025 after a costly Epic EHR rollout and rising drug and supply costs. Leadership says volumes rebounded but margins are squeezed.